GlaxoSmithKline: all 4,196 studies
Page 19 of 42. Open to participants first (141), then studies with results posted, then the rest; newest registration first within each.
- Lamotrigine Extended-Release In Elderly Patients With EpilepsyCompletedNCT00516139Phase 3Results posted
- Safety Study Using GSK573719 And Tiotropium In Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00515502Phase 2Results posted
- Non-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 2-10 Year Old SubjectsCompletedNCT00514904Phase 3Results posted
- Assess Reacto- and Immunogenicity of Pneumococcal Conjugate Vaccine When Given as Booster or a 2 Dose Catch up ScheduleCompletedNCT00513409Phase 2Results posted
- Study to Evaluate the Safety and Immune Response of Two-Doses of Candidate Influenza Vaccine GSK 1557484A in AdultsCompletedNCT00510874Phase 1Results posted
- Co-Administration of Meningococcal Vaccine GSK134612 With Infanrix Hexa™ Versus Individual Administration of Each VaccineCompletedNCT00508261Phase 3Results posted
- Evaluate Reactogenicity & Immunogenicity of an Influenza Pandemic Candidate Vaccine (GSK1562902A) in Primed AdultsCompletedNCT00506350Phase 2Results posted
- Study Of RV-39 In Patients Who Also Have AsthmaTerminatedNCT00503009Phase 4Results posted
- Fluticasone Furoate Nasal Spray Versus Oral FexofenadineCompletedNCT00502775Phase 4Results posted
- Evaluate Safety & Immunogenicity of a Pandemic Influenza Vaccine (GSK1562902A) in ChildrenCompletedNCT00502593Phase 2Results posted
- Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)CompletedNCT00500331Phase 2Results posted
- Multicenter Pilot Study To Define The Marker As An Alternate For Tropism AssayTerminatedNCT00496782Phase 1Results posted
- Prophylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Conjugate Vaccine GSK1024850ACompletedNCT00496015Phase 3Results posted
- Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-NaiveCompletedNCT00495469Phase 2Results posted
- Ofatumumab (Humax-CD20) With CHOP (Cyclophosphamide,Doxorubicin, Vincristine, Predisolone) in Follicular Lymphoma (FL) PatientsCompletedNCT00494780Phase 2Results posted
- Month 30 & 42 Extension Studies of CRD-004 Primary StudyCompletedNCT00492648Phase 2Results posted
- Immunogenicity and Safety of GSK Biologicals' HPV Vaccine 580299 in Healthy Japanese Females 10-15 Years of AgeCompletedNCT00492544Phase 3Results posted
- Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate AlzheimersTerminatedNCT00490568Phase 3Results posted
- Persistence Study of GSK Biologicals' Tdap Vaccine 1, 3, 5 and 9 Years Following Administration as an Initial Single Dose in Healthy Young Adults and to Evaluate the Immunogenicity and Safety of Boostrix as a Second Dose of Tdap, When Administered at Year 9CompletedNCT00489970Phase 3Results posted
- Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of AgeCompletedNCT00489554Phase 3Results posted
- Long-Term Safety of Treximet (Sumatriptan/Naproxen Sodium) for Migraine in AdolescentsCompletedNCT00488514Phase 3Results posted
- Lapatinib in Combination With Weekly Paclitaxel in Patients With ErbB2 Amplified Advanced Gastric CancerCompletedNCT00486954Phase 3Results posted
- A Study to Evaluate the Immune Response and Safety of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine/Cervarix TM Vaccine in Healthy Females Aged 15-25 YearsCompletedNCT00485732Phase 3Results posted
- REQUIP (Ropinirole Hydrochloride) IR Long-Term Phase 4 StudyCompletedNCT00485069Phase 4Results posted
- Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (GSK580299) in Healthy Female Subjects 10-25 Years of Age.CompletedNCT00481767Phase 3Results posted
- Efficacy, Safety, Reactogenicity & Immunogenicity of the Rotarix Vaccine in Japanese InfantsCompletedNCT00480324Phase 3Results posted
- GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung CancerTerminatedNCT00480025Phase 3Results posted
- Lapatinib In Combination With Chemotherapy In Subjects With Relapsed Breast CancerTerminatedNCT00479856Phase 2Results posted
- Multicenter, Safety Study Of MaravirocCompletedNCT00478231Phase 3Results posted
- Lapatinib in Combination With Capecitabine in Japanese Patients With Metastatic Breast CancerCompletedNCT00477464Phase 2Results posted
- Safety & Immunogenicity Study of Meningococcal Vaccine GSK134612 Given With Priorix-Tetra™ to 12-23 Month-Old ChildrenCompletedNCT00474266Phase 3Results posted
- Non-inferiority of GSK Biologicals' DTPw-HBV/Hib Compared to Two Formulations of GSK Biologicals' DTPw-HBV/HibCompletedNCT00473668Phase 3Results posted
- A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.TerminatedNCT00471237Phase 2Results posted
- Immunogenicity and Safety of Meningococcal Vaccine GSK134612 Given as 1 or 2 Doses to Healthy 9-12 Months Old Toddlers.CompletedNCT00471081Phase 2Results posted
- Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation TherapyCompletedNCT00470834Phase 4Results posted
- COMPAS (Clinical Otitis Media & Pneumonia Study): Pneumonia & Acute Otitis Media (AOM ) Efficacy Study of the Pneumococcal Conjugate VaccineCompletedNCT00466947Phase 3Results posted
- Primary Study to Demonstrate Non-inferiority and Immunogenicity of GSK Biologicals' Meningococcal Vaccine 134612CompletedNCT00465816Phase 3Results posted
- Non-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 11-17 Year-Old SubjectsCompletedNCT00464815Phase 3Results posted
- A 5-way Treatment Period Trial of Single Doses of Intranasal GSK256066 in Patients With RhinitisCompletedNCT00464568Phase 2Results posted
- Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same VaccinesCompletedNCT00463437Phase 3Results posted
- Sb-705498 Rectal Pain StudyTerminatedNCT00461682Phase 2Results posted
- SERETIDE 100/50 bd (Twice Daily) Versus FLIXOTIDE 100 bd As Initial Maintenance Therapy In Moderate Asthma In AdultsCompletedNCT00461500Phase 4Results posted
- Study of GSK1358820 In Patients With Post-Stroke Lower Limb SpasticityCompletedNCT00460655Phase 3Results posted
- Study Of GSK1358820 In Patients With Post-Stroke Upper Limb SpasticityCompletedNCT00460564Phase 3Results posted
- Complementary Testing to Evaluate Immunogenicity of Human Papillomavirus (HPV) Vaccine (580299) in Healthy Female Subjects Aged >/= 26 YearsCompletedNCT00456807Phase 3Results posted
- Immune Response to Hepatitis B Vaccine Challenge Dose in Subjects Who Received a Primary Neonatal Hepatitis B Vaccine.CompletedNCT00456625Phase 4Results posted
- SERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII)CompletedNCT00455923Phase 4Results posted
- Study of Long-term Antibody Persistence After a Booster Dose of Menitorix VaccineCompletedNCT00454987Phase 4Results posted
- Immunogenicity and Safety of Meningococcal Vaccine GSK134612 vs. Menactra® in Healthy Adolescent/Adults Aged 10-25 Years.CompletedNCT00454909Phase 2Results posted
- Lot Consistency, Immuno, Safety of Meningococcal Vaccine GSK134612 Given With Fluarix™ to 18-55 Year-Old AdultsCompletedNCT00453986Phase 3Results posted
- A Dose Ascending, Study To Examine The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of GSK233705B.CompletedNCT00453479Phase 2Results posted
- A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg BID To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg BID In Symptomatic Subjects With AsthmaCompletedNCT00452699Phase 4Results posted
- A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg Twice Daily In Symptomatic Patients With AsthmaCompletedNCT00452348Phase 4Results posted
- TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)TerminatedNCT00451321Phase 2Results posted
- HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive AdultsCompletedNCT00450580Phase 3Results posted
- Assess Consistency of Immunogenicity of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) in AdultsCompletedNCT00449670Phase 3Results posted
- Clinical Assessment Of GW815SF Salmeterol/Fluticasone Propionate(HFA MDI) In Pediatric Patients With Bronchial Asthma -A Long Term (24-week) Study-CompletedNCT00449046Phase 3Results posted
- Clinical Assessment Of GW815SF HFA MDI In Pediatric Patients With Bronchial AsthmaCompletedNCT00448435Phase 3Results posted
- Randomized Discontinuation Study of Lapatinib Versus Placebo in Subjects With Documented Tumor Progression After Chemotherapy, or Where no Approved Therapy ExistsTerminatedNCT00447226Phase 2Results posted
- Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)CompletedNCT00443053Phase 3Results posted
- Airway Limitation Study: Study In Primary Care Centers Of Chronic Bronchitis In Long-Term Cigarette Smokers Of At Least 40 Years Of Age With Symptoms Of Cough And Shortness Of BreathCompletedNCT00442468Results posted
- Adefovir Dipivoxil For The Treatment Of Chinese Compensated Chronic Hepatitis B(CHB)PatientsCompletedNCT00441974Phase 4Results posted
- A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 Hydrofluoroalkane (HFA) Versus Fluticasone Propionate 100 HFA In Children With AsthmaCompletedNCT00441441Phase 3Results posted
- A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic AlopeciaCompletedNCT00441116Phase 3Results posted
- Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 InfectionCompletedNCT00440947Phase 3Results posted
- Brain Metastases In ErbB2-Positive Breast CancerTerminatedNCT00437073Phase 2Results posted
- Pharmacoeconomic Consequences Of Analgesia in the Intensive Care Unit (ICU)TerminatedNCT00436345Phase 3Results posted
- Safety and Immunogenicity Study of GSK Biologicals' Malaria Vaccine 257049, When Incorporated Into an EPI RegimenCompletedNCT00436007Phase 2Results posted
- Fluticasone Furoate Nasal Spray Versus Oral FexofenadineCompletedNCT00435461Phase 4Results posted
- Evaluation of Efficacy and Safety of Omacor, Co-Administered With Atorvastatin, in Subjects With HypertriglyceridemiaCompletedNCT00435045Phase 3Results posted
- Safety and Immunogenicity of the Zoster Vaccine GSK1437173A in Elderly SubjectsCompletedNCT00434577Phase 2Results posted
- Dose-ranging Study to Evaluate the Safety & Immunogenicity of a HIV Vaccine 732461 in Healthy HIV Seronegative VolunteersCompletedNCT00434512Phase 2Results posted
- Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease (PD)CompletedNCT00434304Phase 2Results posted
- A Study Of BRL49653C For The Treatment Of Type 2 Diabetes (Combination Therapy With Sulfonyl Urea) -With Placebo StudyCompletedNCT00432679Phase 3Results posted
- A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy Infants.CompletedNCT00432380Phase 2Results posted
- Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical CancerCompletedNCT00430781Phase 2Results posted
- Safety & Immunogenicity of an Alternative Immunization Schedule of GSK Bio's Pandemic Influenza Vaccine (GSK1119711A)CompletedNCT00430521Phase 2Results posted
- Neoadjuvant Study With Chemotherapy, Lapatinib And Trastuzumab In Breast CancerCompletedNCT00429299Phase 2Results posted
- Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's DiseaseCompletedNCT00428090Phase 3Results posted
- Study in Children to Evaluate Non-Inferiority and Persistence up to 5 Years of GSK Bio Meningococcal Vaccine 134612CompletedNCT00427908Phase 2Results posted
- Efficacy Of Eptifibatide Compared To Abciximab In Primary Percutaneous Coronary Intervention (PCI) For Acute ST Elevation Myocardial Infarction (STEMI)CompletedNCT00426751Phase 3Results posted
- Expanded Access Program for Maraviroc At Multiple CentersCompletedNCT00426660Phase 3Results posted
- Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus (HPV) Vaccine With Other Vaccines in Healthy Female SubjectsCompletedNCT00426361Phase 3Results posted
- A Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)CompletedNCT00424476Phase 3Results posted
- Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After SurgeryCompletedNCT00424255Phase 3Results posted
- Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT)CompletedNCT00424177Phase 2Results posted
- Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of AgeCompletedNCT00423046Phase 3Results posted
- Letrozole In Combination With Lapatinib In Neoadjuvant Treatment Of Early Breast CancerCompletedNCT00422903Phase 2Results posted
- Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel SyndromeCompletedNCT00421707Phase 2Results posted
- To Assess Safety, Reactogenicity & Immunogenicity of 2 Doses of GSK's Oral Human Rotavirus Vaccine in Pre-Term InfantsCompletedNCT00420745Phase 3Results posted
- MDD POC Study GSK372475 Subjects Depressive DiseaseCompletedNCT00420641Phase 2Results posted
- Long-term Efficacy and Safety of Subjects Approximately 3 Years After Priming With 2 Doses of GSK Bio's HRV Vaccine.CompletedNCT00420316Phase 3Results posted
- Study to Assess Safety & Immunogenicity of GSK Biologicals' DTPa/Hib Vaccine vs Separate Administration of DTPa and Hib.CompletedNCT00412854Phase 3Results posted
- A Study of Belimumab in Subjects With Systemic Lupus ErythematosusCompletedNCT00410384Phase 3Results posted
- Ofatumumab With Fludarabine and Cyclophosphamide in B-CLL PatientsCompletedNCT00410163Phase 2Results posted
- Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal OsteoporosisCompletedNCT00405392Phase 4Results posted
- The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term LaborCompletedNCT00404768Phase 2Results posted
- Study of Adefovir Dipivoxil for Korean Patients With Chronic Hepatitis B(CHB) Who Have Completed ADF 103814CompletedNCT00403585Phase 4Results posted
- Evaluation of Efficacy and Safety of Lovaza (Omega-3-Acid Ethyl Esters) in Recurrent, Symptomatic Atrial FibrillationCompletedNCT00402363Phase 3Results posted
- Fluticasone Nasal Spray Patient Preference StudyCompletedNCT00398476Phase 3Results posted